From L-R: Curogen board member Craig Gordon, CEO Chang-Woo Lee and COO Arvind Sood
Korean startup Curogen seeks global expansion, new funding to back autoimmune drugs
A South Korean biotech working on multi-specific autoimmune disease treatments is looking to make a leap into the US.
Curogen, based in Seoul and backed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
